Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Genitourinary 1CNS 1

Conditions

Lymphoma 3Testicular Neoplasms 2Teratoma 2Vulvar Neoplasms 1Seminoma 1Recurrence 1Ovarian Neoplasms 1Ovarian Germ Cell Cancer 1Lymphoma, Non-Hodgkin 1Lymphoma, Large B-Cell, Diffuse 1Hemangioma, Capillary 1Hemangioma 1HIV Infections 1Central Nervous System Neoplasms 1Acquired Immunodeficiency Syndrome 1

Interventions

Magnetic Resonance Spectroscopy 8Radiotherapy 7Temozolomide 5Carboplatin 5Vincristine 4etoposide phosphate 3Methotrexate 3Etoposide 3Busulfan 3Biopsy 3Thiotepa 2Surveys and Questionnaires 2Melphalan 2Magnetic Resonance Imaging 2Lomustine 2Cisplatin 2Chemotherapy, Adjuvant 2alovudine 1Yoga 1Ursodeoxycholic Acid 1Topotecan 1Stem Cell Transplantation 1Rituximab 1Remote Consultation 1Radiation 1Psychiatric Rehabilitation 1Peripheral Blood Stem Cell Transplantation 1Paclitaxel 1Oxycodone 1Ocoxin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Central Nervous System Neoplasms × Bleomycin × Clear all
NCT00276718 2013-09-17

Etoposide, Carboplatin, and Bleomycin in Treating Young Patients Undergoing Surgery For Malignant Germ Cell Tumors

National Cancer Institute (NCI)

Phase NA Unknown
100 enrolled
CNSGenitourinaryGynecologic

Ovarian Germ Cell Cancer, Ovarian Neoplasms, Teratoma, Testicular Neoplasms, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡